ArticleJournal of cancer research and clinical oncology2017

Low-dose anti-thymocyte globulin reduce severe acute and chronic graft-versus-host disease after allogeneic stem cell transplantation.

Osamu Imataki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.